The nitric oxide-sensitive guanylyl cyclase/cGMP-dependent protein kinase type I signaling pathway can afford protection against the ischemia/ reperfusion injury that occurs during myocardial infarction. Reportedly, voltage and Ca
M
yocardial infarction (MI) is one of the leading causes of death worldwide. 1 In addition to the acute damage, chronic heart failure may develop after MI, often severely limiting the patient's life. Hence, novel strategies and ideas to improve the outcome after MI are highly desired. Concepts aiming to reduce cardiomyocyte cell death during MI seem promising because the death of cardiomyocytes represents a main cause of morbidity and mortality. Cell death during MI develops in response to the ischemic injury and in addition to reperfusion injury, which refers to the tissue damage caused when blood supply through the vessel is restored. [2] [3] [4] Reperfusion injury contributes to up to 50% of the final infarct size, although fast reopening of the occluded vessel is currently our best clinical therapy available for patients with MI. 5 Mechanical conditioning induced by short repetitive episodes of ischemia either before (ischemic preconditioning [iPre]) [6] [7] [8] [9] [10] or directly after (ischemic postconditioning [iPost]) 11, 12 the ischemic period proved to be an efficient method to reduce cell death and infarct size and thereby to improve outcome in various animal models of MI; however, human trials have not translated these findings into clinical practice. [13] [14] [15] [16] [17] [18] [19] [20] [21] Reportedly, activation of the nitric oxide (NO)-sensitive guanylyl cyclase (NO-GC) pathway signaling via cGMP and cyclic guanosine-3',5'-monophosphate (cGMP)-dependent protein kinase type I (cGKI) exhibited substantial protection against cardiac ischemia/reperfusion (I/R) injury. 8, 11, 22, 23 For example, administration of the NO-GC activator cinaciguat 11, 23 and the stimulator riociguat 22 or inhibition of cGMP-degrading phosphodiesterases, that is among others, phosphodiesterase-5 (PDE5), by using sildenafil, 11, [24] [25] [26] vardenafil, 27 or tadalafil 28 showed beneficial effects in various models of I/R injury and MI. The pharmacological conditioning-like signaling events downstream of cGMP during I/R, however, need further clarification. It was proposed that cGMP/cGKI in cardiomyocytes and in isolated cardiomyocyte mitochondria causes an opening of mitochondrial ATP-dependent potassium channels, 29 which have been shown to prevent the damaging effects of I/R in the heart on activation. 24, [30] [31] [32] These findings attracted our interest because they suggest that cGMP may be an upstream component of a cardioprotective pathway that involves potassium channels in the inner mitochondrial membrane (IMM). In addition to mitochondrial ATP-dependent potassium channels, several groups, including our group, have reported evidence for Ca 2+ -activated K + channels of the BK type (BK) in cardiomyocytes. 33, 34 The pore-forming α subunit of BK is encoded by a single gene (KCNMA1, and usually located at the plasma membrane of cells; however, in cardiomyocytes, BK is exclusively present in the IMM. 33, 34 By studying hearts obtained from mice with a global deletion of the BK channel (BK-KO) in an ex vivo Langendorff perfusion setup, we and others have confirmed that mechanical conditioning acts in favor of the myocardial survival by a BK-dependent effect on I/R 12, 35, 36 via limiting accumulation of excessive reactive oxygen species (ROS). 34 A burst of ROS occurring within the first minutes of reperfusion, when oxygen is reintroduced, seems to be a critical step for initiating a chain of detrimental events eventually leading to mitochondrial dysfunction and cardiomyocyte death. 37 Moreover, BK channel openers such as NS1619 and NS11021 have been shown to prevent cardiac damage when applied before ischemia and at the early onset of reperfusion in different ex vivo settings. 33, 38, 39 However, 1 report did not find evidence for an altered response of the myocardium to the protection afforded by volatile anesthetics in the absence of BK. 40 Because canonical BK channels are directly stimulated by cGMP/cGKI, [41] [42] [43] we hypothesized that the cardioprotection afforded by cGMP-elevating compounds may also require cardiomyocyte-specific BK channel (CMBK) activity to prevent cell death during I/R in vivo. To study this, here we applied an open-chest in situ mouse model of MI and assessed infarct size in global
Clinical Perspective
What Is New?
• CMBK channel deficiency renders the heart highly vulnerable to ischemia and reperfusion injury.
• Beneficial effects of cardioprotective agents that are known to target the nitric oxide-sensitive guanylyl cyclase/cGMP pathway require CMBK.
• Ischemic preconditioning and postconditioning procedures against ischemia/reperfusion injury signal via cardiomyocyte-specific BK channels.
• cGMP/cGMP-dependent protein kinase type I increase the open probability of BK channels in isolated inner membrane patches derived from cardiomyocyte mitochondria.
• Lack of CMBK is associated with compromised post-myocardial infarction heart function and accelerated fibrous tissue deposition.
• Under physiological conditions, CMBK channels modulate contractile and chronotropic properties of the heart.
What Are the Clinical Implications?
• Activation of CMBK may represent a supportive strategy for limiting the cardiac damage during reperfusion therapy in acute myocardial infarction.
• By affecting cardiac contractility and infarct scar formation, CMBK seems to be important for longterm outcome after acute myocardial infarction.
• Collectively, the in vivo data obtained should guide future clinical trials using either approved or new drugs to target a cardiomyocyte-specific nitric oxide-sensitive guanylyl cyclase/cGMP/BK pathway in ischemic heart disease and its complications.
BK-KO and in conditional BK mutants with a cardiomyocyte-or a smooth muscle cell-specific deletion of the BK channel (CMBK-KO or SMBK-KO, respectively) and compared the outcome with their litter-matched controls. To validate the role of endogenous CMBK channels for the usually cardioprotective NO-GC/cGMP/ cGKI pathway, we further studied the effect of cGMPelevating compounds over the course of the myocardial I/R injury in our gene-targeted BK models.
To this end, we identified endogenous CMBK channels as infarct-limiting factors. Opening of CMBK channels measured by the patch-clamp method in ex vivo mitoplast preparations occurs in a cGMP/cGKI-dependent mode and seems to be essential to establish cardioprotection elicited either by mechanical preconditioning and postconditioning procedures or by pharmacological cGMP elevation in vivo.
METHODS
The data, analytical methods, and gene-targeted mouse models used will be made available to other researchers for purposes of reproducing the results or replicating the procedure. Further information in this regard will be made available by contacting the corresponding author.
Animals
All animal experiments were performed with permission of the local authorities and conducted in accordance with the German legislation on the protection of animals. Mice were kept in cages with wooden-chip bedding on a standard 12-hour light/dark cycle with ad libitum access to food and water under temperature and humidity control. Global BK channel-deficient mice (BK −/− genotype) and their wildtype littermates (BK +/+ genotype) on a mixed SV129/C57BL background were bred and maintained at the Institute of Pharmacy, Department of Pharmacology, Toxicology and Clinical Pharmacy, University of Tuebingen, as described before. 44 By crossing transgenic mice that carry a Cre recombinase transgene under control of the myosin heavy chain 6c (αMHC) promotor (αMHC-Cre Tg/+ genotype; stock No. 011038, Jackson Laboratory) 45 Tg/+ representing a tamoxifen-inducible Cre recombinase under the control of the smooth muscle myosin heavy chain 11 promoter. 49 With regard to the floxed BK gene loci, the SMBK-KO mice remained premutant until Cre activation by tamoxifen (1 mg/d IP) for 5 consecutive days. At ≥7 days after the last tamoxifen administration, SMBK-KO and tamoxifen-injected SMBK-CTRs were used for the acute I/R experiments. 46 To study the infarct sizes in the acute I/R model ( Figure I in the online-only Data Supplement), data from global and conditional BK male and female mice were combined because the amount of infarction did not differ between sexes ( Figure II in the online-only Data Supplement). For the SMBK mouse study, only males could be analyzed for their response to the cardiac I/R injury because the CreERT2 transgene was located on the Y chromosome. All animals were investigated at the age of 8 to 16 weeks with no agerelated differences observed ( Figure III in the online-only Data Supplement).
The specificity and efficiency of recombination in the αMHC-Cre transgenic model were assessed after crossing these mice to double-fluorescent ROSA26-tomato reporter animals (ROSA mTG/+ genotype) 50 obtained from Charles River (stock No. 007576, Jackson Laboratory). The genotypes of the different mouse strains and the Cre-mediated somatic recombination events in cardiomyocytes and representative organs were determined by polymerase chain reaction amplification after DNA extraction using primer pairs that specifically identify the wild-type (+), knockout (−), and floxed (fl) BK gene loci as previously described. 44, 45, 49, 50 
Statistical Analysis
All data are presented as mean±SEM. See the online-only Data Supplement for a detailed description of the methods.
RESULTS

Infarct Sizes Are Increased in Mice Globally Lacking BK Channels
We studied the vulnerability of global BK-KO (BK ) mice subjected to different experimental setups, ie, after 30 minutes of ischemia followed by 120 minutes of reperfusion, sham operation without ligation of the coronary artery (I/R sham) or a postconditioning (iPost) protocol consisting of 6 consecutive cycles of reperfusion and reocclusion directly after the ischemic period (I/R+iPost; Figure IA through IC in the online-only Data Supplement). B, Infarct size is expressed as percentage of the risk zone and was significantly increased in BK −/− (n=11) compared with litter-matched BK +/+ (n=8) mice after I/R (left). As expected, sham surgery did not cause myocardial infarction in both genotypes (middle; n=6 per genotype). A significant reduction in infarct size was observed in BK +/+ hearts (n=8) subjected to iPost, whereas BK −/− hearts (n=9) did not respond to this cardioprotective maneuver (right). Bottom, Representative Evans Blue and triphenyltetrazolium chloride double-stained heart slices of the 2 genotypes subjected to different I/R setups (blue, unaffected heart muscle; red plus white, risk zone; white, infarcted tissue; note that some slices showed a central white spot reflecting the ventricular lumen). C, Serum levels of cardiac troponin I (cTnI) determined at the end of reperfusion correlate well with the infarct sizes (n=8 for BK ). All data were assessed with 2-way ANOVA followed by Bonferroni-corrected Student t tests, except for B and C, in which groups were compared by the Welch t test because of unequal variance, and E, in which the Kruskal-Wallis test followed by the Dunn test for multiple pairwise comparisons was performed. *P<0.05, ***P<0.001 for the comparison between BK −/− and BK +/+ groups. §P<0.01, #P<0.001 for comparison with the respective I/R group. genotypes ( Figure 1B , middle, and Figure IB in the online-only Data Supplement), supporting the high specificity and reproducibility of our in vivo I/R approach. Infarct size (as percent of area at risk) after I/R per se was significantly greater in BK-KO (38.56±1.65%; n=11) compared with BK-WT (22.39±1.32%; n=8; Figure 1B , left) mice, suggesting an important role for BK channels for cardiac cell survival regardless of sex or age of the experimental animals ( Figures II and III Figure 1C ). In the isolated and perfused heart model, we have previously observed that iPre requires BK channels to afford cardioprotection. 34 We now extended this finding to an established iPost procedure in vivo ( Figure  IC Figure 1B , right). In support of recent studies that implicated that BK-dependent protection against I/R-induced cell death was stemming from the cardiomyocyte itself, we first investigated the response to hypoxia of adult cardiomyocytes obtained from global BK-KO hearts. Effects of oxygen-deprivation were evaluated by light microscopy and by lactate dehydrogenase release. Compared with BK-WT cardiomyocytes, the data showed a clear tendency toward more cell death ( Figure 1D and 1E); however, this difference in lactate dehydrogenase release did not reach the level of statistical significance. 
Cardiomyocyte-Specific BK Channel Deficiency Results in Impaired Heart Functions In Vivo
To clarify the cellular mechanisms whereby BK channels afford protection against I/R injury and in iPost signaling, we first generated gene-targeted mice lacking BK in cardiomyocytes. In a first series of experiments, we assessed the recombination efficacy and specificity of the cardiomyocyte-restricted Cre recombinase 45 using a 2-color fluorescent reporter system. 50 In the absence of αMHC-Cre activity, we observed ubiquitous expression of the cell membrane-targeted red fluorescent Tomato (mT) protein in the heart and aorta, with the latter being used as control tissue ( Figure 2A and Figure IV in the online-only Data Supplement, left column). As expected, αMHC-Cre-mediated excision of the loxP-flanked mT DNA sequence resulted in an almost complete switch (98.97%) to green fluorescent protein (mG) in cardiomyocytes ( Figure 2A , right, and Figure 2B ), whereas noncardiomyocytes such as coronary and aortic smooth muscle cells continued to express the mT protein ( Figure IV in the online-only Data Supplement, right column). Next, we applied a BKspecific primer set designed to identify the 3 different BK alleles, wild-type (+), floxed (fl), and knockout (−), within 1 sample of different tissues derived from αMHC Tg/+ ;BK +/fl mice. In line with the Cre-reporter study ( Figure 2A and 2B and Figure IV in the online-only Data Supplement), the BK-specific polymerase chain reaction products confirmed efficient recombination of the endogenous BK gene locus in atrial and ventricular cardiomyocytes ( Figure 2C ). In contrast, conversion of the floxed BK allele was not observed in DNA purified from skeletal muscle, white adipose tissue ( Figure 2C ), brain, liver, or aorta (data not shown). In line with the conversion of the floxed BK DNA sequence to the respective (−) allele in cardiomyocytes ( Figure 2C ), immunoblots using 2 different BK antibodies revealed a substantial decrease in BK channel protein levels from CMBK-KO mitochondria purified from cardiomyocytes ( Figure 2D and 2E). CMBK-mutant mice did not develop any obvious phenotype and exhibited normal body and heart weights ( To investigate whether these differences in cardiac functionality were related to changes in hemodynamic parameters, telemetric blood pressure recordings were performed. Mean arterial pressure (Figure 3D ) was reduced in CMBK-KO mice (100.93±1.33 mm Hg [n=10]) compared with litter-matched CMBKCTRs (108.21±2.62 mm Hg [n=7]) with no effect on pulse pressure ( Figure 3E ) or activity (data not shown). Lower mean arterial pressure was related to an effect on systolic and diastolic values, but only for the latter did this difference reach the significance level (P<0.001; data not shown).
Cardiomyocyte-Specific BK-KOs Show a High Susceptibility to I/R Damage
As observed in the global BK-KO mice, I/R vulnerability of cardiomyocyte-specific BK channel mutants was higher compared with the respective control mice (38. Figure 4C ). To verify that the higher vulnerability of the CMBK-KO hearts to the I/R stimulus was not caused by an unexpected hemodynamic response under anesthesia, blood pressure was measured in unconscious mice. Anesthesia induced by pentobarbital-Na + injection resulted in a comparable decrease in the mean arterial pressure of CMBK-CTR and CMBK-KO mice ( Figure  VIA in the online-only Data Supplement), suggesting that the differences in infarct size between genotypes were unrelated to the hypotension observed after CMBK channel ablation ( Figure 3D ). Moreover, we measured coronary flow during reperfusion after 30 minutes of ischemia in isolated Langendorff-perfused CMBK-KO and CMBK-CTR hearts with no apparent differences between genotypes (Figure VIB and VIC in the online-only Data Supplement). To further exclude the possibility that vascular BK channels affect the cardiac I/R phenotype, we subjected gene-targeted mice carrying a smooth muscle cell-specific ablation of the BK channel (SMBK-KO, SMBK −/fl ) 46 to the I/R injury. After Cre-mediated conversion of the floxed BK locus specifically in smooth muscle cells ( Figure VIIA in the online-only Data Supplement), tamoxifen-treated SMBK-KO and SMBK-CTR mice were examined for their response to the I/R procedure and iPost. SMBK-KO mice, in contrast with the CMBK-deficient mutants, exhibited infarct sizes similar to their respective litter-matched controls and areas at risk that did not differ between SMBK-deficient and -proficient mice ( Figure VIIB and VIIC in the online-only Data Supplement). Together, the findings from different gene-targeted mouse models support the notion that CMBK, but not SMBK, channels are key elements of a cardioprotective pathway.
CMBK Ablation Affects ROS Formation, Apoptosis, and the Reperfusion Injury Salvage Kinase Pathway at I/R
We and others have previously presented in vitro evidence for a link between BK channels exclusively localized at the IMM of the cardiomyocytes and ROS dynamics during hypoxia. 34 Because ROS is a major determinant of the myocardial damage at I/R in vivo, we herein investigated whether the enlarged infarct sizes in CMBK-KOs were caused by an effect on the amount of cardiac ROS production. In vivo mitochondrial production of superoxide leading to hydrogen peroxide formation can be estimated by defining the ratio of MitoP to MitoB after a single MitoB bolus. 51 At baseline, we observed a mildly reduced MitoP/MitoB ratio in CMBK-KOs, which was elevated after I/R (Figure VIIIA in the online-only Data Supplement). Normalization of the values demonstrated a significant higher increase in hydrogen peroxide formation in I/R-exposed CMBK-deficient hearts ( Figure 4D ), an effect that was unrelated to the expression of ROS-degrading enzymes such as CuZnSOD (SOD1) and MnSOD (SOD2) ( Figure  VIIIB through VIIID in the online-only Data Supplement). Furthermore, at normoxia, mitochondria from BK-proficient and -deficient cardiomyocytes displayed no defects in any of the bioenergetics variables studied ( Figure IXA ORIGINAL RESEARCH ARTICLE ment). Cell death by apoptotic mechanisms represents a further indicator of outcome after MI. 52 Apoptosis was determined by DNA strand breaks using the terminal deoxynucleotidyl transferase dUTP nick-end labeling method on 8 equidistant regions between the cardiac apex and the ligation ( Figure 4E) . Overall, the number of terminal deoxynucleotidyl transferase dUTP nick-end labeling-positive cells in CMBK-mutant hearts (3.99±0.81%) was higher compared with CMBK-CTR hearts (2.64±0.52% [n=3 per genotype]; Figure 4F ) after I/R. In a central area covering heart regions 2 to 4, which relate to a pronounced part of the infarct according to the triphenyltetrazolium chloride staining, apoptosis rates between genotypes were significantly different with higher values for CMBK-KO hearts ( Figure 4G ). Apparently, CMBK activity affects both forms of cell death that occur simultaneously during MI. Activation of the prosurvival kinases of the reperfusion injury salvage kinase (RISK) pathway extracellular signal-regulated kinase (ERK) and AKT 53, 54 was assessed with phospho (p)-specific antibodies. After I/R with 10 minutes of reperfusion (I/R 10 ) p-ERK/ERK and p-AKT/AKT ratios showed a small but significant increase in CMBK-CTR heart lysates, which was less pronounced in the absence of CMBK channels ( Figure 4H and 4I) .
Mechanical Conditioning Procedures, Pharmacological Conditioning by cGMPElevating Compounds, and Direct Activators of BK Protect the Heart via BK Channels in Cardiomyocytes
As expected, mechanical conditioning either by iPost or by iPre procedures ( Figure IC and ID in the onlineonly Data Supplement) efficiently protected CMBK-CTR hearts from I/R damage (iPost infarct size, 11.27±0.62%; iPre infarct size, 13.13±1.05%). The beneficial effects of both mechanical interventions were largely attenuat- Figure 5A ). A direct comparison of infarct size at iPost (in percent to I/R without stimulus) between CMBK-positive and -negative hearts revealed that cardiomyocyte-specific BK channels account for >50% of the protection afforded by iPost ( Figure 5B, left) . Compared with CMBK-KO hearts, the beneficial effects of the iPost procedure on global BK-KO hearts were lower ( Figure 5B, right) , suggesting either remaining traces of CMBK channel activity in the Cre-based model (Figure 2D and 2E ) or noncardiomyocyte BK channels as additional mediators of the signaling elicited by iPost. To test whether the acute targeting of the BK resembles the cardiac I/R damage observed in the gene-targeted models, we used paxilline, an established BK blocker ( Figure IE in Figure 5C , left). Paxilline had no significant effect on the I/R damage that develops in response to I/R in CMBK-deficient hearts (compare Figure 4B with Figure 5C , left, and Figure 5D , left). Conversely, we used the BK channel opener NS11021 to test for cardioprotective effects of CMBK activation ( Figure IF in the online-only Data Supplement). A significant reduction in infarct size by 44.7±5.6% was observed when NS11021 (9.2 µg/kg) was administered to ; RIO, n=10; CIN, n=8). B, Reduction (percent) in infarct size after administration of RIO and CIN compared with baseline ischemia/reperfusion (I/R) injury ( Figure 4B ). C, Injection of the PDE5 blockers sildenafil (SIL; n=8 per genotype) and tadalafil (TAD; n=9 per genotype) resulted in a significant reduction in infarct size in CMBK +/fl but not in CMBK −/fl mice. D, Reduction (percent) in infarct size after treatment with SIL and TAD compared with baseline I/R injury ( Figure 4B ). E, CMBK +/fl did not respond to the cardioprotective stimulus elicited by ischemic postconditioning (iPost) or SIL after pretreatment with the nitric oxide synthase blocker N ω -nitro-l-arginine methyl ester (L-NAME; n=8 per genotype and setup). F, Alterations in infarct size (in percent of I/R; Figure 4B ) after L-NAME cotreatment compared with I/R+iPost (or SIL) without L-NAME administration ( Figures 5B and 6D) . Representative heart slices of the respective genotype and setup are shown at the bottom of A, C, and E). Pharmacological preconditioning and postconditioning protocols (A through F) are summarized in Figure IG CMBK-CTR mice before reperfusion (NS11021 infarct size, 15.05±1.52% [n=8]; Figure 5C and 5D, right), whereas the protection elicited by NS11021 was significantly lower in CMBK-KO hearts (NS11021 infarct size, 32.66±0.82% [n=8]; Figure 5C , right). With 9.2 µg/kg NS11021, we did not notice any toxic side effects; however, with a higher dose of the compound (ie, 92 µg/ kg), we observed that 37.5% of the experimental mice died during reperfusion regardless of their genotype. Control experiments performed using the solvents used for paxilline or NS11021 showed that the solvents did not affect infarct size formation at I/R conditions ( Figure  VD in the online-only Data Supplement).
Because canonical BK channels usually present at the plasma membrane of various cell types are directly phosphorylated by cGMP/cGKI, 43 we studied whether the infarct-limiting effects of pharmacological modulators that stimulate the NO-GC/cGMP/cGKI pathway involve CMBK channels.
Neither the cardiac expression of cGKI nor its enzyme activity, which was monitored by assessing the phosphorylation of the Ser239 residue in the vasodilator-stimulated phosphoprotein, was affected by the lack of CMBK channels (Figure X in the online-only Data Supplement). I/R 10 resulted in a mild increase in phosphorylated vasodilator-stimulated phosphoprotein level but no apparent differences between both genotypes. In the presence of CMBK, both the NO-GC stimulator riociguat ( Figure IG 
Mitochondrial BK Channels in Isolated Membrane Patches Are Directly Activated by cGMP/cGKI
In our quest to understand how cGMP and mitochondrial BK channels in cardiomyocytes are connected at a molecular level, we used 2 different antibodies specifically recognizing common regions in the major cardiovascular cGMP effector protein cGKI. By studying total heart lysates and purified mitochondrial protein fractions derived from BK-deficient and -proficient cardio- myocyte mitochondria, we demonstrated that cGKI is present in the lysates and in the mitochondrial protein fraction, whereas cytosolic or plasma membrane-bound proteins such as α-tubulin-or β 1 -adrenoreceptor, respectively, were not observed in the mitochondrial protein fraction ( Figure 7A and Figure XIVA through XIVC in the online-only Data Supplement). To test whether cGMP/cGKI directly modulates mitochondrial BK activity, we performed patch-clamp experiments on isolated mitoplast membrane patches obtained from cardiomyocyte mitochondria by osmotic swelling ( Figure XV in the online-only Data Supplement). Previously, 3 active mitoplast channels of 370, 120, and 60 pS and a BK-specific channel activity of 190 pS were detected in whole mitoplasts derived from BK-proficient cardiomyocytes. 34 All but the last conductance were observed in BK-deficient mitoplasts. In the present patch-clamp approach using IMMs, we detect all of the previously identified channel conductances; however, because of differences in ionic composition, the corresponding conductance activities were 345 (not shown), 145, 95, and 35 pS (not shown) (Figure 7) . In good agreement with our previous report, the 145-pS conductance was detected in 65% IMM patches from BK-WT (n=70) but not in BK-KO mitoplasts (n=33). Besides a slightly smaller conductance, this channel displayed a linear current-voltage relationship ( Figure 7B ) and several other characteristics of the canonical BK channel usually present at the plasma membrane of cells ( Figure 7C and 7D) . As reported previously, 34 the mitochondrial BK opened with rare bursts with short closed dwell times at negative voltages and at positive voltages with longer and more frequent openings ( Figure 7C ). Moreover, the open probability (P o ) of the channel was sensitive to Ca 2+ ( Figure 7D , left), stimulated by NS11021, and inhibited by paxilline ( Figure 7D , right), which allowed us to assign the 145-pS activity with high confidence to the mitochondrial BK channel. A prevailing conductance of a rather similar appearance (95 pS) was present in BK-WT and BK-KO IMM patches, suggesting that it constitutes a channel different from BK ( Figure 7F ). To investigate whether cGMP/cGKI modulates the mitochondrial BK channel, we measured IMM patches displaying BK in the presence of Mg 2+ /ATP, the cGMP analog 8-Br-cGMP, and cGKI ( Figure 7E and 7F) . Consistent with previous observations, the presence of Mg 2+ /ATP caused a significantly lower P o of the mitochondrial BK. 55 Subsequent addition of cGMP and cGKI to the same patches dramatically increased the P o as a strong indicator for the positive regulation of mitochondrial BK occurring as a result of the 8-Br-cGMP/cGKIdependent phosphorylation of the channel. This stimulated channel activity was sensitive to paxilline and was found very frequently in mitoplasts derived from BK-WT cardiomyocytes (n=7), whereas neither the 95-pS channel activity (n=5) nor the 345-pS channel activity (data not shown) in BK-KO mitoplasts was modulated by cGMP/cGKI ( Figure 7F ). Collectively, these electrophysiological experiments on IMM patches establish evidence for a molecular connection between cGMP/cGKI and BK channel function at the IMM. 
Lack of CMBK Channels Aggravates Cardiac Dysfunctions After MI
So far, our data support the notion that CMBK channels prevent acute I/R injury. To test for a potential role of BK for the long-term outcome after I/R, we investigated a chronic mouse model of MI with 30 minutes of ischemia followed by 4 weeks of reperfusion (I/R 4wks ). Overall survival of the CMBK-KO and CMBK-CTR mice and their post-MI heart weights ( Table II in the online-only Data Supplement) were not different. Longitudinal strain, which characterizes the endocardial shortening of the myocardial fibers during systole (diastole=0; Figure 8A ), represents one of the earliest and most sensitive markers of cardiac dysfunction. 56, 57 We assessed the synchronicity of the longitudinal strain by echocardiography in 6 endocardial segments during systole and diastole in CMBK-KO mice and observed mild alteration under basal conditions ( Figure XVIA and XVIB in the online-only Data Supplement) and a heavily disturbed synchronicity after I/R 4wks ( Figure  XVIC and XVID in the online-only Data Supplement). In particular, in the anterior apex region, myocardial deformation was dramatically altered in the absence of CMBK. Quantification of the longitudinal strain ( Figure 8A ) over all segments confirmed abnormal myocardial tissue deformation for CMBK-KO (−9.77±0.76%) compared with litter-matched control hearts (−12.38±0.97% [n=13 per genotype]; Figure 8B ) and for both genotypes a significantly impaired deformation after MI compared with basal levels (P<0.001; Figure 8B and Figure 
DISCUSSION
At the moment, the best clinical therapy for the management of an acute MI represents the fast reopening of the occluded coronary artery. In addition to the ischemic episode during MI, reperfusion damage of previously viable tissue is a major cause of cardiomyocyte death. 2 Strategies to target reperfusion injury have been studied extensively but with little success in patients. 21, 58 The modulation of the NO-GC/cGMP/cGKI pathway has attracted increasing attention because a number of studies suggested its infarct-limiting capacities. 11, [22] [23] [24] [25] [26] 28 However, little is known about the mechanisms and downstream targets of this cardioprotective pathway. In addition to mitochondrial K + channels of the K ATP type, which reportedly oppose mitochondrial dysfunction, excessive ROS production, and Ca 2+ overload, and hence the opening of the mitochondrial permeability transition pore, 24, 29, 30, 32 we assessed whether BK channels present in cardiomyocyte mitochondria are needed to allow the cardioprotective signaling elicited by iPre, iPost, and cGMP elevation in an in vivo model of I/R. 31, 35, 36 We studied I/R in mice with a global deletion of the BK channel and conditional mutants lacking the BK channel exclusively in cardiomyocytes and compared the outcome with the corresponding litter-matched controls or with gene-targeted mutants lacking BK in smooth muscle cells. Infarct size was significantly increased in global BK-KO mice ( Figure 1B) , indicating that functional BK channels are important modulators of the myocardial response to the I/R injury, an effect that was seen independently of the presence or absence of any cardioprotective stimuli. In contrast, global BK-KO hearts did not show evidence for a higher I/R vulnerability ex vivo, 34 and infarct size per se was not sensitive to the BK channel blocker paxilline applied to Langendorff-perfused wild-type hearts. 26 Apparently, the integration of the heart at the whole-animal level is important to permit anti-infarct effects via endogenous BK channels. Because these initial analyses of the global BK-KOs did not allow us to conclude that the protection afforded was a result of the BK in the cardiomyocyte or other cardiac cell types, we assessed the amount of ischemic myocardium after I/R injury in 2 conditional mouse mutant lines that lack the BK channel either in cardiomyocytes or in smooth muscle cells. Indeed, CMBK-KO mice ( Figure 4B ), but not SMBK-KO mice ( Figure VIIC in the online-only Data Supplement), subjected to the I/R injury exhibited cardiac damages that amounted to the levels seen in global BK-KOs ( Figure 1B) , a finding that was confirmed by the elevated cTnI levels in the serum of both global and cardiomyocyte-specific BK-KOs ( Figures 1C and 4C) . The significant increase in the I/Rinduced apoptotic cell death of CMBK-negative hearts ( Figure 4G ) further supports the notion that CMBKs are the major BK channel population to protect cardio-ORIGINAL RESEARCH ARTICLE myocytes against the detrimental events elicited by I/R, an effect that was not related to changes in coronary flow ( Figure VIB and VIC in the online-only Data Supplement). Our approaches modulating the activity of BK by pharmacological means are consistent with the I/R data from the tissue-specific BK mouse models. Accordingly, the BK blocker paxilline ( Figure 5C ) or the BK opener NS11021 ( Figure 5C ) aggravated or limited the infarcts of CMBK-proficient animals, respectively. By comparing these results with the response of the CMBK-deficient hearts to paxilline and NS11021, we recognized an inadequate level of cardiomyocyte-specific BK channel activity as a major determinant of I/R-induced cell death. NS11021 has previously been used with success in ex vivo studies to induce cardioprotection, 38, 59 a finding that we extended to show the favorable impact of this compound on infarct size in vivo ( Figure 5C ). In this regard, it is important to note that we also recognized a dose-dependent toxicity of NS11021 (data not shown). However, specific openers of this channel should be further investigated toward a potential improvement of cardioprotective therapies in patients with acute MI.
Mitochondrial ROS, that is, superoxide that leads to the formation of hydrogen peroxide, can exert contrasting effects on the cardiac muscle during I/R. For example, a burst of ROS occurring at the early onset of reperfusion triggers the opening of the mitochondrial permeability transition pore, which induces the collapse of the mitochondrial membrane potential, leading to ATP depletion and cell death, 60 whereas low amounts of ROS lead to cardioprotection. 30 In the in vivo I/R model, the elevated myocardial damage observed in the CMBK-deficient hearts correlated with a small but significantly higher ROS increase after I/R compared with normoxic levels ( Figure 4D ). Because isolated mitochondria obtained from global BK-KO hearts produce a higher level of ROS after anoxia followed by reoxygenation, 34 we conclude that functional BK channels regulate ROS homeostasis in oxidatively stressed cardiomyocyte mitochondria. Obviously, additional evidence is needed to establish the link between excessive mitochondrial ROS amounts and the dynamics of the K + influx and efflux pathways (potentially involving, for example, connexin43) in the I/R-exposed IMM. [61] [62] [63] [64] [65] A high mitochondrial matrix K + content reportedly provoke a mild uncoupling of the electron transport chain, thereby leading to low amounts of ROS that eventually activate protein kinase C and the cardioprotective RISK pathway. 30, 31 In addition to the link between mitochondrial K + channels and ROS, BK activity may confer cardioprotection at reperfusion by opposing the Ca 2+ overload that mediates mitochondrial permeability transition pore opening and maintains the membrane potential. 33, 35, 36, 66, 67 The putative signaling mechanisms involving BK in the cardiomyocyte during I/R in vivo and the mechanistic limitations of the present study are summarized in Figure XVIIA and XVIIB in the online-only Data Supplement.
Prosurvival protein kinases of the RISK pathway represent important signaling elements that confer cardioprotection at I/R in mice and rats; however, their activation has also been studied in larger animals with inconsistent results. 25, [68] [69] [70] At the onset of reperfusion, phosphorylation of ERK1/2 and AKT seems to limit mitochondrial permeability transition pore opening and thereby myocardial infarct size through various downstream targets of the RISK pathway, which include glycogen synthase kinase-3β and endothelial NO synthase, among others ( Figure XVIA and XVIB in the online-only Data Supplement).
31,54,71 p-ERK1/2 and p-AKT levels were less increased after I/R 10 in cardiomyocyte-specific BK-KO hearts ( Figure 4H ), suggesting that proper recruitment of AKT-and ERK1/2-dependent pathways requires the opening of BK channels. The RISK pathway is activated in the setting of iPost, and we demonstrate that mechanical conditioning by iPost (and iPre) involves cardiomyocyte-specific BK channels. About 50% of the protection elicited by iPost in control hearts was lost in the absence of CMBK ( Figure 5B ). Residual protection by iPost in the CMBK-KO heart may be established through recruitment of K ATP channels. Indeed, a large body of work suggests that mitochondrial K ATP channel opening plays a role in cardioprotection elicited by ischemic and pharmacological preconditioning and by iPost. 72 Consistent with this concept, the infarct area in I/R-exposed hearts from mice globally lacking BK was ≈10% smaller with iPost than as a result of the I/R injury per se ( Figure 5B ). The differences in the response of the 2 gene-targeted BK mouse lines were expected because yet-to-be-identified nonmyocyte BK channels may also play at least a minor role for iPost to establish full cardioprotection and because the depletion of the cardiomyocyte-specific BK protein in the conditional mouse model did not reach the level of the global BK-KOs ( Figure 2D and 2E) .
The NO-GC/cGMP pathway has been intensively studied for its cardioprotective properties in mice and in other animal models of I/R injury. Mechanisms responsible for the protective actions, that is, the downstream effectors of the pathway, remain to be fully elucidated. Independently, a number of investigators observed that either pharmacological modulators of NO-GC 11, 22, 23 or inhibitors of cGMP-degrading phosphodiesterases 11, 25, 28 exert cardioprotection via cGKI in the cardiomyocyte. 11 In contrast with the high vulnerability of the CMBK-deficient myocardium, a loss of cardiomyocyte-specific cGKI activity per se did not render the heart more or less resistant to the I/R injury. 11 Apparently, the pathophysiological reaction of the cardiac muscle is modulated by mitochondrial BK channels, whereas the significance of the NO-GC/cGMP/ cGKI pathway in controlling infarct formation is best seen in mechanical and pharmacological conditioning-like settings. With regard to a link between NO-GC/cGMP and BK in the I/R exposed myocardium, our findings suggest that the opening of cardiomyocyte-specific BK channels is an essential step in establishing protection by cGMP and cGMP-elevating compounds. For example, either the stimulation of NO-GC by riociguat at the onset of reperfusion or application of a preconditioning-like protocol with the NO-GC activator cinaciguat produced powerful cardioprotection when functional CMBK channels were present ( Figure 6A ). Because cinaciguat resulted in a cardiomyocyte-specific increase in cGMP levels, we suggest that the cGMP cascade was indeed stimulated under these experimental conditions ( Figure XI in the onlineonly Data Supplement). In addition to the infarct-limiting effects of NO-GC/cGMP, cardioprotection induced by sildenafil seems to be through cardiac BK channel complexes. A knock-down of the accessory β 1 subunit of the BK channel before I/R or coadministration of the BK channel blocker paxilline efficiently blocked the beneficial effects of sildenafil in the ex vivo Langendorff-perfused heart model. 26, 73 In accordance with these studies, we applied sildenafil at the onset of reperfusion ( Figure 6C and 6D), and at the concentration used, its cardioprotective potential was observed only in BK-proficient mice. By adopting a previously published preconditioning-like protocol, 28 we also used tadalafil as an alternative and more selective inhibitor of the cGMP-degrading PDE5. In agreement with the sildenafil treatment study, the favorable effects of tadalafil on infarct formation were abolished in the CMBK gene-targeted mutants ( Figure 6C and 6D). Collectively, these findings point to the recruitment of a cardiomyocyte-specific BK channel to a cardioprotective cGMP/PDE5 pathway after the I/R injury. Because the presence of PDE5 in the cardiomyocytes is a matter of ongoing debate, 74 it is important to consider noncardiomyocytes such as endothelial cells, immune cells, or fibroblasts as the primary target of sildenafil and tadalafil. Taking all these considerations into account, we believe that it is possible that PDE5 inhibition during cardiac I/R involves the transfer of a protective signal from the noncardiomyocytes to the cardiomyocytes. Paracrine features that may orchestrate a CMBK-dependent pathway in cardiomyocytes may involve, for example, the induction or suppression of cytokines and growth factors. However, the precise nature of the I/R-triggered intercellular communication between the different cardiac cell types is still elusive and awaits further investigation. 75 Our combined pharmacological and genetic strategy did not clarify how NO-GC/cGMP interacts with the CMBK channel in vivo; that is, it remains unclear whereby the cytoplasmic cGMP signal conferred with a potassium channel at the IMM. In addition to other lines of evidence provided by this study, the presence of the cGKI protein in mitochondrial fractions obtained from cardiomyocytes further suggests that the protective signal is transduced via the cGMP/cGKI pathway ( Figure 7A ). This notion is also supported by the electrophysiological measurements that demonstrated a direct molecular connection between cGMP/cGKI and BK channel in purified IMM patches (Figure 7E and 7F) . Finally, our data also support the view that sildenafil, sildenafil-sensitive cGMP-phosphodiesterase, and iPost act through a NO-GC-dependent cGMP pathway against cardiac damage because N ω -nitro-l-arginine methyl ester abolished any favorable effect of sildenafil or iPost on infarct size ( Figure 6E ). 76 In contrast with global BK-KO mice, CMBK mutants exhibited low blood pressure under physiological conditions. 77 Mild hypotension was accompanied by slight decreases in heart rate, fractional shortening, and ejection fraction ( Figure 3 and data not shown) . Because renovascular, baroreceptor, and neuroendocrine mechanisms that usually maintain blood pressure homeostasis should not be affected by the cardiomyocyte-specific ablation of the BK channel in CMBK-mutant mice, we suggest an intrinsic cardiac dysfunction as a major cause for the blood pressure phenotype. Previously, we observed a reduction of oxidative phosphorylation capacity and thus a deficit in ATP generation of isolated ventricular muscle fibers obtained from global BK-KO mice. 34 However, mitochondrial bioenergetics, at least as measured in cell-free cardiomyocyte mitochondria, seem to be intact ( Figure IX in the online-only Data Supplement), together suggesting a more complex cross-talk between BK channel function and ATP generation in mitochondria with putative upstream elements on the cytoplasmic side of the cardiomyocyte or muscle fiber. To this end, we speculate that the impaired cellular energy production by the mitochondrial oxidative phosphorylation system in vivo is linked to an abnormal resting heart rate and cardiac malfunctions in the CMBK-KO mouse model.
On the basis of the findings from the acute model, we studied the long-term outcome of CMBK-KO mice subjected to a chronic in vivo model of MI. Although we did not observe differences in heart weight or ejection fraction between mice lacking CMBK and their litter-matched controls after ischemia followed by 4 weeks of reperfusion, longitudinal strain as an early and sensitive marker for cardiac dysfunction 56, 57 was significantly reduced in CMBK-KO (Figure 8 ). This functional deterioration was related to an increase in fibrotic scar formation, indicating that the CMBK channels also may turn out to be important classifiers for the long-term prognosis after MI.
CONCLUSIONS
The presented data establish infarct-limiting effects for endogenous cardiomyocyte-specific BK channels during I/R injury. Lack of CMBK resulted in mitochondrial ROS overproduction, an increase in cardiomyocyte apoptosis, and an improper activation of the prosurvival kinases ERK1/2 and AKT (summarized in Figure XVII in the online-only Data Supplement). Our supporting long-term study also implied a role for CMBK in limiting
